Halozyme (HALO) Enters Global Collaboration, Licensing Agreement with Lilly (LLY) for ENHANZE Platform
Tweet Send to a Friend
Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced a global collaboration and license agreement with Eli Lilly and Company (NYSE: LLY) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
